Skip to main content
. Author manuscript; available in PMC: 2019 Aug 6.
Published in final edited form as: Nature. 2019 Feb 6;566(7743):270–274. doi: 10.1038/s41586-019-0916-x

Extended Data Fig. 2 |. Characterizations of immune phenotypes of Ythdf1-deficient mice.

Extended Data Fig. 2 |

(a) data points for Fig. 1a. (b) WT or Ythdf1−/− mice were injected s.c. with 106 B16-OVAcells. Tumor survival were monitored. Mice with tumor volumes less than 200 mm3 are considered to be surviving. One of three representative experiments is shown. (c) data points for Fig. 1b. d-h, WT or Ythdf1−/− mice were injected s.c. with 106 B16-OVAcells. (d,e) The frequency of tumor infiltrating MDSC (Ly6c+CD11b+) cells was assessed 12 days post tumor inoculation. (f,g) The percentages of Treg in spleen, draining lymph node (DLN) and tumor are shown. (h) Degranulation of tumor NK cells in response to in vitro re-stimulation with PMA/ionomycin. (i) data points for Fig. 1d. Data are representative of two independent experiments (a, c). n, numbers of mice. Data are mean ± s.e.m. and were analyzed by two-tailed unpaired Student’s t-test for (a, c, e, g-i) and two- tailed log-rank (Mantel-Cox) test (b).